It was during many emergency transportations and a great length of time working in hospitals that Dr. Benoît Cailleteau designed a completely new concept in gathering and managing urine for those hospitalised or not, with reduced mobility or bed bound.
What he has created is an external use, catheter-free urine bag that protects the user from any risk of infection and gives them back their autonomy.
Indeed, while rushing a patient with an aneurysm of the abdominal aorta to hospital, Dr. Cailleteau found himself with a problem that was technically impossible to resolve given that the patient had ripped out their urinary catheter. There was no medical equipment suited to the situation.
Dr. Cailleteau sought to design a revolutionary device to replace the one which has held a monopoly on urine collection since the Middle Ages: the urinal.
The aim was to create an easy-to-use, intuitive device, for external use, that respected the physiology of the urinary apparatus, that was non-invasive, completely reliable and that would enable any one - male or female - to urinate while lying down in an autonomous and safe way.
His research resulted in the design of the Urocomfor™ and then the Urinex™ concept and the registering of international patents which means these products are the only ones of their kind and are completely original because of the following characteristics:
- the non-return valve: makes them much easier to fill and reliably watertight.
- the opening: optimises the concept making it usable by both men and women.
Because of this dynamic, the characteristics of Urocomfor™ and Urinex™ make them easier to use and guarantee that they are as safe as possible.
The concept stands out not only because of the research that went into the design but also the technology involved in making it which can be defined as real "know-how", in order to ensure it is possible to envisage industrial scale development to match Dr. Cailleteau's aims: European and worldwide.
The certainty that he had discovered a concept worthy of the 21st century encouraged Dr. Cailleteau to persevere by founding a company, M3AT, to ensure the device's development and production.
This invention has also been designed with public health in mind, to effectively combat hospital-acquired infections which are a plague in our countries and on our economies. Indeed, the resurgence of these infections is something that has focussed the attention of political and economic powers in Western countries, in a search for effective, affordable and rational solutions. In Europe these infections account for between 30 and 40% of all infections acquired in the hospital environment. The social and economic costs of such infections amount to billions of euros each year.
This is what makes Urocomfor™ and Urinex™ an essential tool in the fight against such infections.
Also, Urocomfor™ and Urinex™ free up "nursing time" by enabling each patient to manage their urine freely and autonomously, thus improving the logistics of hospital beds and significantly reducing the length of time of an in-patient stay.
So Urocomfor™ and Urinex™ optimise a hospital's efficiency and enable care staff to add that human touch that makes a hospital not only a "place of care" but also a "place for living".
> ACA conference
M3AT will give a world preview of its Urinex™, the first single-use female urine collector, at the ACA conference and exhibition in Glasgow on May 20 to 21, 2013.
Bacteriological study of urinals: Results.
The various studies conducted by M3AT have drawn the following conclusion:
- That no bacteriological study on the reusable medical devices given to patients has been carried out.
- That there is no study auditing the performances of medical accoutrements used for the same application.
That is why M3AT asked an independent laboratory to carry out such a study, following a clearly defined protocol.
In France it has been acknowledged that 6 to 7% of hospitalisations are further complicated by a nosocomial infection of varying levels of gravity. That amounts to 750,000 cases per 15 million hospital admissions annually.
The origins of 40% of the infections are linked to invasive procedures, the most common of which is fitting a urinary catheter. So we know who the guilty party is: the catheter.
There are 9,000 deaths per year in France. It is the third most common cause of death after cardio-vascular disease and cancer. So fitting a urinary catheter kills because the urethra is the biggest point of entry for nosocomial infections. The emissary being the colon, the anus, the closer the entry orifice is, the greater the risk.
The annual cost is estimated at: 2.4 - 6 billion euros wasted. That is the equivalent of €3,500 to €8,000 per infection.
This waste will increase with the compensations scheme that, since a law was passed on December 30, 2002, renders health establishments automatically responsible for the risk from infections.
> Technological progress in the battle against hospital-acquired infections and savings for health services…
After two years of research and development, M3AT SA, based in Botterens in the canton of Fribourg, announced the launch of industrial-scale production and distribution in Europe of a range of completely innovative products: single-use urine collectors for men and women, the Urocomfor and the Urinex.
Find out more
> Assessment of the national programme for the prevention of nosocomial infections
Find out more
10 avril 2013
> Label CTI Start-up label
M3AT S.A., which has its head offices in Botterens (CH), has just been awarded the CTI Start-up label from the Commission for Innovation and Technology, part of the Federal Department of Economic Affairs, Education and Search.
20 mai 2013
> PromoCon/ACA Prize
Swiss company M3AT wins the PromCon/ACA "Look Good, Feel Good" (LGFG) award for Urinex™.
DOWNLOAD FOR FREE
Did you know?
Chamber pot, Urinatorium, Ourētris, Piss pot, Po, Urinal...
See the pdf: History of the Urinal Down the Centuries.